CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company focused on developing the next generation of proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at the Rodman & Renshaw 5th Annual Global Healthcare Conference, which is being held on May 19-20, 2008 in Monte Carlo, Monaco. Curis’ presentation will take place on Monday, May 19th at 9:30 a.m. Eastern Daylight Time (3:30 p.m. local time).
